FDA Inspection
Tedor Pharma, Inc.Tedor Pharma, Inc. – FDA Inspection, Jun 5, 2025
Record Details
This FDA Inspection record concerns Tedor Pharma, Inc., with an inspection on June 5, 2025, issued by the New England District Office, covering human drugs.
View Company Profile
ID · d130b166-4fa4-417a-9823-05222a5913f9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1271887
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tedor Pharma, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2019 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| April 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 29, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 9, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tedor Pharma, Inc.
- FDA Inspection 1077786 - 2019-01-31
- FDA Inspection 1010372 - 2017-04-20
- FDA Inspection 853221 - 2013-10-29
- FDA Inspection 743987 - 2011-09-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.